Assessing the impact and cost-effectiveness of long-acting PrEP for HIV prevention

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact and cost-effectiveness of long-acting PrEP through discrete choice experiments and analysis of routine service data. It involves conducting in-depth interviews and focus group discussions with HIV-negative men who have sex with men (MSM) and transgender women (TGW) to identify key attributes influencing PrEP use. The findings will inform mathematical modeling to assess user preferences and the overall effectiveness of PrEP strategies. The study aims to provide insights that can enhance PrEP uptake and optimize resource allocation in HIV prevention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Minimum age of 18 years
* Individual assigned male at birth reporting sex with men in the past 12 months
* Self-reported HIV-negative MSM and TGW who either report interest in PrEP use, current PrEP use, or past PrEP use
* Permit audio recording during the interview and/or discussion.

Exclusion Criteria:

* Not willing to participate in the study

Where it's running

• Rainbow Sky Association of Thailand (RSAT)
  Bangkok, Bangkapi, Thailand Recruiting
• The Service Workers In Group Foundation (SWING)
  Bangkok, Building 3, Patpong, Surawong Road, Thailand Recruiting
• The Service Workers In Group Foundation (SWING)
  Bang Lamung, Changwat Chon Buri, Thailand Recruiting
• Rainbow Sky Association of Thailand (RSAT)
  Chon Buri, Changwat Chon Buri, Thailand Recruiting
• Rainbow Sky Association of Thailand (RSAT)
  Hat Yai, Changwat Songkhla, Thailand Recruiting
• Tangerine Clinic
  Bangkok, Pathumwan, Thailand Recruiting

Study contacts

• Principal investigator: Nittaya Phanuphak, MD,PhD. — Institute of HIV Research and Innovation Foundation
• Study coordinator: Nittaya Phanuphak, MD,PhD.
• Email: nittaya.p@ihri.org
• Phone: 6681 825 3544

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

• Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV

  This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.

  Recruiting Tourcoing Hospital · Tourcoing · NCT07745530

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.